MapLight Therapeutics closed its initial public offering at $17.00 a share, and the underwriters exercised their option for more shares in full. Its lead drug has no Phase 2 results yet.
Latest Goldman Sachs Group news
We have not published a story on Goldman Sachs Group yet. When there is news, it will appear here.
Questions about Goldman Sachs Group
What is the ticker symbol of Goldman Sachs Group?
Goldman Sachs Group Inc trades under the ticker GS on NYSE.
Where is Goldman Sachs Group listed?
Goldman Sachs Group Inc is listed on NYSE.
Which country or territory is Goldman Sachs Group listed under?
Our directory records Goldman Sachs Group Inc under Not recorded.
Does aibio.space cover Goldman Sachs Group?
aibio.space lists Goldman Sachs Group Inc among 2,820 public biotech companies and publishes its news here as stories appear.
Which other companies' news mentions Goldman Sachs Group?
Goldman Sachs Group is named in 1 of our story about other companies, most recently: "MapLight IPO closes; additional-share option brings gross proceeds to $288.4 million" (Oct 28, 2025). Source.
How can I follow Goldman Sachs Group (GS) news?
Press Follow on this page to add Goldman Sachs Group to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming Goldman Sachs Group so far, in Financings.
Investor discussion: Goldman Sachs Group
Members talk about Goldman Sachs Group (GS). Reader posts, not aibio.space reporting, and not investment advice.
Rules
Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.
Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.
Stock chart
Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NYSE:GS on TradingView.
Listing details
Goldman Sachs Group Inc is a public biotech or pharmaceutical company listed on NYSE under the ticker GS, recorded under Not recorded. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Company
Goldman Sachs Group Inc
Ticker
GS
Listing
NYSE
Country or territory
Not recorded
Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.
Published and maintained by aibio.space. Not investment advice. How we work.
Who manages this pageThis page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio